Published in PLoS One on September 03, 2013
Chromatin interaction analysis reveals changes in small chromosome and telomere clustering between epithelial and breast cancer cells. Genome Biol (2015) 0.98
C-ing the Genome: A Compendium of Chromosome Conformation Capture Methods to Study Higher-Order Chromatin Organization. J Cell Physiol (2016) 0.90
Chromosomes at Work: Organization of Chromosome Territories in the Interphase Nucleus. J Cell Biochem (2016) 0.82
Implications of COMT long-range interactions on the phenotypic variability of 22q11.2 deletion syndrome. Nucleus (2013) 0.82
Locus-specific gene repositioning in prostate cancer. Mol Biol Cell (2015) 0.82
Tissue-of-origin-specific gene repositioning in breast and prostate cancer. Histochem Cell Biol (2016) 0.82
Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors. Retrovirology (2014) 0.81
Nuclear actions of insulin-like growth factor binding protein-3. Gene (2015) 0.81
Cell type specific alterations in interchromosomal networks across the cell cycle. PLoS Comput Biol (2014) 0.78
Wide-scale alterations in interchromosomal organization in breast cancer cells: defining a network of interacting chromosomes. Hum Mol Genet (2014) 0.77
Spatial Genome Organization and Its Emerging Role as a Potential Diagnosis Tool. Front Genet (2016) 0.75
Genetic sequence-based prediction of long-range chromatin interactions suggests a potential role of short tandem repeat sequences in genome organization. BMC Bioinformatics (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science (2009) 29.83
Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37
Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature (2009) 13.45
An oestrogen-receptor-alpha-bound human chromatin interactome. Nature (2009) 12.16
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
Beyond the sequence: cellular organization of genome function. Cell (2007) 10.32
Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet (2007) 9.88
Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol (1995) 9.03
Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell (2012) 8.41
FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res (2006) 7.72
CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science (2006) 7.68
Interchromosomal associations between alternatively expressed loci. Nature (2005) 7.45
Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol (2001) 7.22
A three-dimensional model of the yeast genome. Nature (2010) 7.01
Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev (2002) 6.43
Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat Genet (2009) 6.39
Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol (2005) 6.18
Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell (2009) 5.74
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74
Visualization of focal sites of transcription within human nuclei. EMBO J (1993) 5.06
Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome Res (2007) 4.99
Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types. Genome Res (2010) 4.67
Genome architectures revealed by tethered chromosome conformation capture and population-based modeling. Nat Biotechnol (2011) 4.56
Transient homologous chromosome pairing marks the onset of X inactivation. Science (2006) 4.45
Concern Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci U S A (2008) 4.31
SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27
A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res (2008) 4.06
Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell (2012) 4.02
Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet (2003) 3.91
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol (2010) 3.75
Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nat Cell Biol (2006) 3.66
The dynamic architecture of Hox gene clusters. Science (2011) 3.58
Induced chromosomal proximity and gene fusions in prostate cancer. Science (2009) 3.31
Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res (2008) 2.62
Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem (1997) 2.44
Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes Chromosomes Cancer (2002) 2.04
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol (2002) 2.01
IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer Res (2011) 1.87
Determining long-range chromatin interactions for selected genomic sites using 4C-seq technology: from fixation to computation. Methods (2012) 1.85
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci U S A (2011) 1.82
Locus-specific and activity-independent gene repositioning during early tumorigenesis. J Cell Biol (2008) 1.56
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res (1997) 1.54
Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci U S A (2012) 1.40
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2006) 1.39
Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res (1995) 1.38
Mobility and immobility of chromatin in transcription and genome stability. Curr Opin Genet Dev (2007) 1.37
Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer (2004) 1.36
Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. Cancer Res (2004) 1.28
Close proximity to Igh is a contributing factor to AID-mediated translocations. Mol Cell (2012) 1.23
The yin and yang of chromatin spatial organization. Genome Biol (2010) 1.20
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.20
Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. Int J Cancer (2007) 1.16
Insulin-like growth factor-binding protein-3 and breast cancer survival. Int J Cancer (1998) 1.14
Disease-specific gene repositioning in breast cancer. J Cell Biol (2009) 1.13
Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem (1993) 1.13
IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments. Oncogene (2012) 1.07
Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. J Clin Endocrinol Metab (2004) 1.05
Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Hum Mol Genet (2009) 0.99
Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2. Biochem Biophys Res Commun (2005) 0.97
Detecting long-range chromatin interactions using the chromosome conformation capture sequencing (4C-seq) method. Methods Mol Biol (2012) 0.93
Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor. Cancer Res (2009) 0.90
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer. Cell Cycle (2006) 0.90
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res (2009) 23.27
Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science (2010) 12.39
Global mapping of protein-DNA interactions in vivo by digital genomic footprinting. Nat Methods (2009) 10.17
Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays. Nat Methods (2006) 8.52
CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science (2006) 7.68
A three-dimensional model of the yeast genome. Nature (2010) 7.01
Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res (2012) 4.80
A critical assessment of Mus musculus gene function prediction using integrated genomic evidence. Genome Biol (2008) 4.78
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 4.73
Unsupervised segmentation of continuous genomic data. Bioinformatics (2007) 3.35
Widely distributed noncoding purifying selection in the human genome. Proc Natl Acad Sci U S A (2007) 2.71
Identification of higher-order functional domains in the human ENCODE regions. Genome Res (2007) 2.62
CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol Cell Biol (2008) 2.24
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol (2003) 2.18
Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med (2007) 2.16
Vitamin D deficiency in older men. J Clin Endocrinol Metab (2009) 2.13
Rapid and accurate peptide identification from tandem mass spectra. J Proteome Res (2008) 2.13
Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol (2003) 1.94
Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med (2008) 1.78
Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology (2006) 1.75
Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med (2009) 1.71
Long-term surveillance of growth hormone therapy. J Clin Endocrinol Metab (2011) 1.64
Mammalian X upregulation is associated with enhanced transcription initiation, RNA half-life, and MOF-mediated H4K16 acetylation. Dev Cell (2013) 1.61
Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse. Hum Mol Genet (2004) 1.58
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum Mol Genet (2003) 1.54
Sex hormones and the risk of incident prostate cancer. Urology (2010) 1.52
Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell (2013) 1.52
The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab (2009) 1.52
Predictive regulatory models in Drosophila melanogaster by integrative inference of transcriptional networks. Genome Res (2012) 1.47
Integrative phenomics reveals insight into the structure of phenotypic diversity in budding yeast. Genome Res (2013) 1.47
Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res (2010) 1.40
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res (2003) 1.36
Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res (2010) 1.35
Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer (2010) 1.34
The spring-loaded genome: nucleosome redistributions are widespread, transient, and DNA-directed. Genome Res (2013) 1.27
A dynamic Bayesian network for identifying protein-binding footprints from single molecule-based sequencing data. Bioinformatics (2010) 1.26
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer (2004) 1.24
A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest (2003) 1.23
Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J Am Geriatr Soc (2011) 1.23
IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Mol Hum Reprod (2005) 1.22
Mortality risk in older men associated with changes in weight, lean mass, and fat mass. J Am Geriatr Soc (2011) 1.22
Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med (2004) 1.21
Optimized clinical performance of growth hormone with an expanded genetic code. Proc Natl Acad Sci U S A (2011) 1.20
The histone code regulating expression of the imprinted mouse Igf2r gene. Endocrinology (2003) 1.20
Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus. J Cell Biol (2014) 1.20
Independent and complementary methods for large-scale structural analysis of mammalian chromatin. Genome Res (2007) 1.19
Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. EMBO J (2006) 1.19
Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions. J Biol Chem (2009) 1.15
Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab (2009) 1.14
Effects of an oral growth hormone secretagogue in older adults. J Clin Endocrinol Metab (2009) 1.13
Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II. J Cell Biol (2011) 1.12
A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis. Clin Cancer Res (2003) 1.12
A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele. Mol Endocrinol (2008) 1.12
Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab (2010) 1.11
Maintaining replication origins in the face of genomic change. Genome Res (2012) 1.10
High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men. J Bone Miner Res (2009) 1.09
Learning sparse models for a dynamic Bayesian network classifier of protein secondary structure. BMC Bioinformatics (2011) 1.09
Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metab (2007) 1.08
CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. Endocrinology (2003) 1.07
Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J Am Geriatr Soc (2010) 1.07
Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Cancer Res (2003) 1.06
A new pairwise kernel for biological network inference with support vector machines. BMC Bioinformatics (2007) 1.05
Large-scale prediction of protein-protein interactions from structures. BMC Bioinformatics (2010) 1.03
Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors. Mol Ther (2008) 1.02
Thyroid function and mortality in older men: a prospective study. J Clin Endocrinol Metab (2012) 1.01
Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care (2011) 1.00
Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Hum Mol Genet (2009) 0.99
Three weeks of caloric restriction alters protein metabolism in normal-weight, young men. Am J Physiol Endocrinol Metab (2005) 0.99
An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoa. J Biol Chem (2002) 0.99
Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells. Int J Cancer (2013) 0.98
IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology (2011) 0.97
Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites. J Cell Biochem (2003) 0.96
Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors. Cancer Genet Cytogenet (2004) 0.96
Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines. Hum Mol Genet (2013) 0.95
Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men. J Bone Miner Res (2010) 0.95
Activating and silencing histone modifications form independent allelic switch regions in the imprinted Gnas gene. Hum Mol Genet (2004) 0.94
Using machine learning to speed up manual image annotation: application to a 3D imaging protocol for measuring single cell gene expression in the developing C. elegans embryo. BMC Bioinformatics (2010) 0.94
Endocrine responses to acute and chronic high-altitude exposure (4,300 meters): modulating effects of caloric restriction. Am J Physiol Endocrinol Metab (2005) 0.91
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes Control (2010) 0.91
An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies. Int J Cancer (2014) 0.91
Transient in vitro epigenetic reprogramming of skin fibroblasts into multipotent cells. Biomaterials (2009) 0.90
Bone mineral density in pediatric transplant recipients. Transplantation (2003) 0.90
Six Degree-of-Freedom Measurements of Human Mild Traumatic Brain Injury. Ann Biomed Eng (2014) 0.89
Fracture risk in diabetic elderly men: the MrOS study. Diabetologia (2014) 0.88
Abdominal myosteatosis is independently associated with hyperinsulinemia and insulin resistance among older men without diabetes. Obesity (Silver Spring) (2013) 0.87
Epigenetics of long-range chromatin interactions. Pediatr Res (2007) 0.86
Validation of FRC, a fracture risk assessment tool, in a cohort of older men: the Osteoporotic Fractures in Men (MrOS) Study. J Clin Densitom (2012) 0.85
Genomic data visualization on the Web. Bioinformatics (2004) 0.85
Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy. Growth Horm IGF Res (2006) 0.84
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system. Mol Cancer (2012) 0.84
Association of a high mobility group gene (HMGA2) variant with bone mineral density. Bone (2009) 0.83
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: MANAGEMENT OF ACROMEGALY PATIENTS: WHAT IS THE ROLE OF PRE-OPERATIVE MEDICAL THERAPY? Endocr Pract (2015) 0.83
The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res (2012) 0.83
Combining classifiers for improved classification of proteins from sequence or structure. BMC Bioinformatics (2008) 0.83
Precursor charge state prediction for electron transfer dissociation tandem mass spectra. J Proteome Res (2010) 0.82
Do capacitively coupled electric fields accelerate tibial stress fracture healing? A randomized controlled trial. Am J Sports Med (2007) 0.82
Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts. Int J Cancer (2011) 0.82
Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab (2011) 0.82